{"transactions":[{"id":941100,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T11:15:20.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, with 25% vesting on January 8, 2027 and the remaining option shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":1650000,"derivative":{"exercise_price":11.06,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001193125-26-009663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526009663/ownership.xml","form_type":"4"}},{"id":941099,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-12T11:15:20.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":367500,"source":{"system":"sec-edgar","filing":"0001193125-26-009663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526009663/ownership.xml","form_type":"4"}},{"id":1008297,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-04T14:25:50.000Z","date":"2025-11-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments over a period of four years, with the first vesting date on December 3, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":8.01,"expiration_date":"2035-11-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-25-263710","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525263710/ownership.xml","form_type":"4"}},{"id":1020673,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-09T16:22:11.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":25172,"price":0.8217,"value":20683.8324,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8205 to $0.8225 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54347,"source":{"system":"sec-edgar","filing":"0001876563-25-000004","document":"form4-10092025_081007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000187656325000004/form4-10092025_081007.xml","form_type":"4"}},{"id":1082629,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-23T18:09:44.000Z","date":"2025-07-22","kind":"sale","planned":false,"acquired":false,"shares":29176,"price":0.92,"value":26841.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was affected pursuant to a \"sell to cover\" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person.  Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":79519,"source":{"system":"sec-edgar","filing":"0001415889-25-020200","document":"form4-07232025_100740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000141588925020200/form4-07232025_100740.xml","form_type":"4"}},{"id":1118089,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T21:51:20.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":37500,"derivative":{"exercise_price":3.51,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000950170-25-083912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025083912/ownership.xml","form_type":"4"}},{"id":1118088,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T21:51:20.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0000950170-25-083912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025083912/ownership.xml","form_type":"4"}},{"id":1449183,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-24T16:17:16.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":108695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSU shall vest in two equal installments on July 22, 2025 and July 22, 2026, subject to the Reporting Person's continuous service through each such date."}],"balance_after":108695,"source":{"system":"sec-edgar","filing":"0001415889-24-020042","document":"form4-07242024_080713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000141588924020042/form4-07242024_080713.xml","form_type":"4"}},{"id":1474407,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T16:15:33.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award shall vest and become fully exercisable on the earlier to occur of (a) June 17, 2025 and (b) the date of the Issuer's next annual meeting of its stockholders."}],"balance_after":49000,"derivative":{"exercise_price":0.71,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001415889-24-017391","document":"form4-06182024_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000141588924017391/form4-06182024_040618.xml","form_type":"4"}},{"id":1487041,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T21:21:54.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":37500,"derivative":{"exercise_price":7.41,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000950170-24-070906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024070906/ownership.xml","form_type":"4"}},{"id":1487040,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T21:21:54.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":11250,"source":{"system":"sec-edgar","filing":"0000950170-24-070906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024070906/ownership.xml","form_type":"4"}},{"id":1859952,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T17:16:39.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option shall vest on June 9, 2024, with the remainder vesting in 8 equal quarterly installments thereafter."}],"balance_after":52000,"derivative":{"exercise_price":1.01,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001104659-23-070005","document":"tm2318326-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465923070005/tm2318326-6_4seq1.xml","form_type":"4"}},{"id":1862572,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T01:33:34.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 6, 2023, subject to the Reporting Person's continuous service  with the Issuer as of each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.55,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-015014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015014/doc4.xml","form_type":"4"}},{"id":1862571,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:33:34.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 6, 2024 and (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-23-015014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015014/doc4.xml","form_type":"4"}},{"id":2220316,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":69524,"kind":"person","name":"Peters Malte","position":1,"cik":"0001876563","reported_name":"Peters Malte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T20:29:28.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.9,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-024401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924322024401/doc4.xml","form_type":"4"}}]}